UK Government Moves to Combat Low Uptake of Innovative Cancer Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
A report highlighting the low use of innovative cancer drugs in the U.K. has prompted the government to target more funding at this area. It may involve a shake-up of NICE, which the pharmaceutical industry has welcomed.